{"nct_id":"NCT01777308","title":"Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination","status":"COMPLETED","status_verified_date":"2017-09","start_date":"2013-05-03","start_date_type":null,"primary_completion_date":"2014-07-03","primary_completion_date_type":"ACTUAL","completion_date":"2016-04-20","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}